![](/img/cover-not-exists.png)
Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen.
Lehner, F., Sommerer, C., Arns, W., Reinke, P., Eisenberger, U., Wuthrich, R., Pressmar, K., Hauser, I., Porstner, M., May, C., Paulus, E., Muehlfeld, A., Suwelack, B., Wolters, H., Witzke, O., Stahl,Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-02074
Date:
July, 2014
File:
PDF, 202 KB
2014